Target intelligence / Profile preview

5S ribosomal RNA pseudogene 430 (RNA5SP430)

Target
RNA5SP430
Molecular classification
Other (pseudogene, non-coding RNA)
01

Overview

5S ribosomal RNA pseudogene 430 (RNA5SP430) is a processed pseudogene derived from the 5S ribosomal RNA gene.[2] Pseudogenes are typically non-functional sequences generated by retrotransposition or gene duplication followed by disabling mutations[2]. While some pseudogenes can be transcribed and may participate in gene regulatory networks—such as acting as antisense transcripts or affecting epigenetic states[2]—most, including those with conventional "RNA5SP" nomenclature, do not encode proteins or functional RNAs and are not considered viable therapeutic targets for drug intervention[2][4]. The canonical 5S ribosomal RNA is a core structural RNA within the large ribosomal subunit involved in ribosome assembly and function[1][3][5], but its pseudogene derivatives like RNA5SP430 lack those roles. There is no evidence that 5S rRNA pseudogenes such as RNA5SP430 have established relevance in disease mechanisms, clinical biomarkers, or pharmacology[2][4]. Key points for structural mapping and downstream use: - "RNA, 5S ribosomal pseudogene 430" is best classified as a processed pseudogene and not as a functional ribosomal RNA, receptor, enzyme, transporter, or drug target[2][4]. If structuring target information for databases or drug discovery, this entry should be designated as non-target and flagged for potential misannotation.

Other names
RN5S430RNA5SP430RNA, 5S ribosomal 430
02

Biological functions

No known active biological function; pseudogenes may regulate parental gene expression through RNA mechanisms
03

Disease associations

Other (no clearly established direct association with diseases)

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 430 (RNA5SP430).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 430 (RNA5SP430).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call